2010
DOI: 10.1007/s10096-010-0992-1
|View full text |Cite
|
Sign up to set email alerts
|

Absence of bacterial resistance to medical-grade manuka honey

Abstract: were exposed to sub-lethal concentrations of manuka honey in continuous and stepwise training experiments to determine whether susceptibility to honey diminished. Reduced susceptibilities to manuka honey in the test organisms during long-term stepwise resistance training were found, but these changes were not permanent and honey-resistant mutants were not detected. The risk of bacteria acquiring resistance to honey will be low if high concentrations are maintained clinically.Response to Reviewers: Dear Editor,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
141
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 153 publications
(152 citation statements)
references
References 19 publications
5
141
0
1
Order By: Relevance
“…The dilution of honey does not seem to affect the antimicrobial properties; MGO has been shown to remain active upon dilution but additional undefined factors are believed to maintain cidality when MGO is diluted below 0.53 mg ml 21 (Jervis- Bardy et al, 2011). Unlike systemic antibiotics and other topical antimicrobials, the risk of bacterial resistance to manuka honey was low, even when high usage was maintained and to date, no 'honey-resistant' isolates have been found (Blair et al, 2009;Cooper et al, 2010). Therefore, manuka honey represents an efficacious and safe alternative to failing systemic and topical treatments that are currently used to treat wounds that are infected with S. pyogenes.…”
Section: Discussionmentioning
confidence: 99%
“…The dilution of honey does not seem to affect the antimicrobial properties; MGO has been shown to remain active upon dilution but additional undefined factors are believed to maintain cidality when MGO is diluted below 0.53 mg ml 21 (Jervis- Bardy et al, 2011). Unlike systemic antibiotics and other topical antimicrobials, the risk of bacterial resistance to manuka honey was low, even when high usage was maintained and to date, no 'honey-resistant' isolates have been found (Blair et al, 2009;Cooper et al, 2010). Therefore, manuka honey represents an efficacious and safe alternative to failing systemic and topical treatments that are currently used to treat wounds that are infected with S. pyogenes.…”
Section: Discussionmentioning
confidence: 99%
“…Minimum inhibitory concentration (MIC) was used to determine the lowest concentration of honey-in-water solution (w/v) at which the percentage inhibition is almost 100% [21,22]. The MIC before and after heat-treatment of SH hydrogen peroxide, although involved in antibacterial action [27][28][29][30][31][32].…”
Section: Antibacterial Capacity Assays Minimum Inhibitory Concentratimentioning
confidence: 99%
“…Many in vitro studies have shown antimicrobial activity of different honeys against a wide range of skin-colonizing and foodborne bacterial species, including antibiotic-resistant bacteria (Mundo et al 2004;Lusby et al 2005;Lin et al 2009;Kwakman et al 2008Kwakman et al , 2010. It has been shown that also in vivo honey has beneficial actions against wound infections (Robson et al 2009), and licensed honey products are widely used in wound care (Cooper et al 2010). Recently, significant antimicrobial activity of engineered organic honey against wound infections has been reported (Dryden et al 2014).…”
Section: Introductionmentioning
confidence: 99%